We're a healthcare IT company. Which CVCs from major hospital systems or insurance companies are investing?

For a healthcare IT company, the most relevant corporate venture capital (CVC) investors are typically health systems (provider-side strategic investors) and payers/insurers (risk-bearing organizations). These investors often bring more than capital: pilot sites, enterprise introductions, clinical validation, and payer/provider distribution.

Below are the major players to know.

Health system CVCs (provider-side)

Insurance / payer CVCs

Particularly relevant targets for a healthcare IT company

If you sell enterprise software to hospitals, I would prioritize:

1. CommonSpirit Ventures — strategic fit with large health system deployment.
2. Providence Ventures — historically active in health IT.
3. UPMC Enterprises — strong commercialization orientation.
4. Kaiser Permanente Ventures — strong fit for care delivery and population health technologies.
5. Mass General Brigham AIDIF — especially if your product involves AI, automation, or clinical workflows.

If you sell into payers, risk-bearing providers, or value-based care, I would emphasize:

1. Optum Ventures
2. CVS Health Ventures
3. Cigna Ventures
4. Cobalt Ventures
5. Carelon Ventures

A useful fundraising strategy is often to pair one of these strategic CVCs with a traditional healthcare VC: the CVC provides validation, distribution, and enterprise access, while the financial VC helps with scaling and governance.

Corporate Venture Capital (CVC) arms from major insurers and integrated delivery networks (IDNs) remain active, though their deployment strategies have shifted toward proven, AI-enabled, workflow-automating, and cost-reducing healthcare IT rather than speculative early-stage software.

The most active and relevant CVCs in the payer and provider spaces actively writing checks for healthcare IT include:

1. Major Health Insurance CVCs

• Optum Ventures (UnitedHealth Group): Undeniably one of the most prolific strategic investors in health tech, managing billions across multiple active funds. They target products that easily scale across payer, employer, and provider channels. Recent deployment has favored data infrastructure, cardiovascular care platforms, and clinical automation (such as backing ambient AI documentation leader Ambience).
• CVS Health Ventures (CVS Health / Aetna): Backed by a $100M+ strategic fund targeting consumer-centric health, care delivery transformation, and disruptive tech enablement. They frequently co-invest and pilot technologies directly within their Aetna and retail footprint. Recent notable plays include heavy investments in generative AI provider solutions like Abridge and provider data management/AI automation tools like H1.
• Ensemble Innovation Ventures: Operates as a hybrid corporate venture fund focusing specifically on software and tech-enabled services designed to optimize back-office and point-of-care workflows for payers, providers, and commercial healthcare entities. They predominantly target Series A/B rounds.

2. Major Hospital System & Integrated Delivery Network (IDN) CVCs

• Kaiser Permanente Ventures (KPV): The dedicated venture arm of Kaiser Permanente, KPV has backed over 170 companies. They focus tightly on digital health, healthcare IT, data analytics, and care-delivery modification that proves measurable clinical and financial value within integrated systems.
• Mayo Clinic Ventures / Strategic Innovation Funds: Mayo Clinic actively invests in and co-develops commercial medical tech and digital health solutions, prioritizing intellectual property and high-impact clinical workflow/diagnostic software that can be validated directly inside Mayo's clinical ecosystem.
• Allumia Ventures (formerly Providence Ventures): Originally the captive CVC for Providence (one of the largest U.S. health systems), Providence Ventures spun out to become an independent venture firm (Allumia), but they maintain deep strategic ties and continuity with major mission-driven health systems, investing heavily in digital health and healthcare IT.

What These CVCs Are Currently Prioritizing for IT

• Administrative & Clinical AI: Generative AI for clinical documentation, coding automation, and streamlining prior authorizations.
• Payer-Provider Interoperability: Solutions reducing friction in data exchange, care coordination, and value-based care tracking.
• Provider Data Accuracy: Real-time directory and credentialing automation (e.g., CVS/H1 alignment).

If you'd like to narrow this down, tell me:

• What is your healthcare IT product's core focus (e.g., administrative workflow, clinical AI, revenue cycle, interoperability)?
• What is your current funding stage (Seed, Series A, Series B+)?

I can help map out which specific fund aligns best or how to position your value proposition for a strategic pilot.

Yes. If you're a healthcare IT company, there is a fairly strong set of strategic CVCs attached to major health systems and payers that are actively investing—not just maintaining legacy portfolios.

I’d prioritize them roughly as follows based on recent investment activity + relevance to enterprise healthcare IT + strategic value.

Highest-priority health-system CVCs

UPMC is particularly interesting because its venture arm explicitly combines the provider system with UPMC Health Plan's payer perspective, giving it unusually strong provider + payer strategic relevance.

Intermountain is another one I'd put near the top: its stated investment areas include Enterprise Enablement, Care Site Optimization, Workforce Transformation, Consumer Experience, Clinical Advancement and Proactive Care. Its portfolio includes healthcare IT companies such as Artisight, Axuall, Sevaro and Stepful.

Kaiser is especially compelling for a company selling into health systems. Its fund explicitly targets Health Information Technology (Enterprise Solutions) and digital health, and recent activity includes investments in Garner and Innovaccer.

UNC is worth watching closely because the new $125M commitment was announced only last week, signaling a significant ramp-up rather than a dormant strategic fund.

Highest-priority payer / insurer CVCs

CVS Health Ventures is particularly interesting

CVS has been very active in 2026. Recent investments include:

• H1 — $40M, with CVS Health Ventures leading the round. H1 provides AI/data infrastructure around healthcare providers and provider directories.
• Fathom — strategic investment for autonomous medical coding/RCM.
• Codoxo — $35M
• Big Health — $23.7M
• Simile — $200M Series B, with CVS participating.

That's a particularly good signal if your product touches AI, RCM, provider data, payer-provider workflows, care management, or administrative automation.

Optum Ventures is probably the other must-have

Optum's 2026 activity includes:

• Bunkerhill Health — agentic AI for health systems
• Adaptive Innovations — $50M Series A
• Amigo AI — $11M Series A
• Chamber Cardio — $60M Series A
• Indigo — $50M Series B
• RISA Labs — $11.1M Series A
• Greater Good Health — $33M
• Imagine Pediatrics — $67M

Its portfolio also includes major healthcare AI companies such as Ambience Healthcare.

For an enterprise health-IT company, Optum is strategically powerful because you're potentially getting both a capital partner and access to one of the country's largest payer/provider platforms.

Cigna Ventures

Cigna's venture arm is also quite substantial: it reports $700M AUM and 24 investments, focusing on early- and growth-stage whole-person health services and technology.

Cigna says its investment themes include insights & analytics, digital health/experience, and care delivery/enablement.

My suggested target list

If I were building your fundraising pipeline, I'd probably start with these 10:

1. Optum Ventures
2. CVS Health Ventures
3. Kaiser Permanente Ventures
4. UPMC Enterprises
5. Intermountain Ventures
6. Cigna Ventures
7. Mayo Clinic Ventures
8. Northwell Ventures / Northwell Holdings
9. Mount Sinai Ventures
10. UNC Health Ventures

There's an important distinction, though: the best CVC for you depends heavily on what your healthcare IT actually does. For example, an RCM/AI company should approach a very different subset than a clinical workflow, interoperability, cybersecurity, or patient-engagement company.

If you tell me what your product does, who buys it (health systems, payers, providers, pharma, etc.), ARR/revenue range, and current funding stage, I can narrow this to a ranked list of ~15 CVCs with partner names, recent comparable investments, check-size/stage, and why each is a fit.

My suggested target list

If I were building your fundraising pipeline, I'd probably start with these 10:

CVS has been very active in 2026. Recent investments include:

For a healthcare IT company, targeting the right Corporate Venture Capital (CVC) arms from major payers and health systems is all about matching your solution (workflow automation, clinical AI, interoperability, data analytics) with their specific strategic mandates.

The most active and influential corporate venture funds from major hospital systems and insurance companies actively investing in digital health and healthcare IT include the following:

Major Insurance/Payer CVCs

1. Optum Ventures (UnitedHealth Group)
   • Focus: Digital health, data analytics, care delivery tools, and foundational healthcare IT. With a massive portfolio of over 70+ companies, they are one of the most prolific and aggressive strategic investors in the space, looking for tech that scales across administrative and clinical workflows.
2. • Focus: Consumer-centric health, whole-person care, and disruptive technology enablement (such as generative AI infrastructure). They look for solutions that can leverage the massive footprint of CVS, Aetna, and Caremark. Notable recent investments include generative AI documentation platforms like Abridge.
3. Cigna Ventures
   • Focus: Insights-driven analytics, digital health enablement, and care coordination tech that improves patient outcomes and affordability. They frequently co-invest in high-growth enterprise health IT.
4. Echo Health Ventures (Cambia Health Solutions & Blue Cross Blue Shield Association affiliates)
   • Focus: Health care IT, marketplace solutions, and tech-enabled services that accelerate the transition to value-based care and consumer-friendly navigation.
5. BCBS Venture Partners (Blue Cross Blue Shield companies)
   • Focus: Early-to-growth stage companies that strategically align with Blue Cross Blue Shield plans nationwide, emphasizing administrative efficiency, cost reduction, and care delivery innovation.

Major Health System/Hospital CVCs

1. Kaiser Permanente Ventures
   • Focus: Digital health, medical devices, and health IT that directly impacts integrated delivery systems, virtual care, and clinical efficiency. They prefer solutions that can be pilot-tested and scaled directly within Kaiser’s massive member and hospital network.
2. Ascension Ventures
   • Focus: Healthcare IT, tech-enabled services, and medical devices. Backed by a collaborative of major Catholic health systems, they focus heavily on operational efficiencies and clinical quality improvement that their parent systems can adopt.
3. Allumia Ventures (formerly Providence Ventures)
   • Focus: Commercial-stage health IT, digital health, and tech-enabled services designed to improve clinical outcomes, lower the total cost of care, and streamline health system operations.
4. MemorialCare Innovation Fund
   • Focus: IT, digital health, medical devices, and clinical services. They uniquely look for companies where they can act as an early adopter/beta site while providing capital and strategic guidance.
5. Mass General Brigham AI & Digital Innovation Fund (AIDIF)
   • Focus: Early-stage artificial intelligence and digital health technologies. If your healthcare IT product features a robust clinical AI or data-infrastructure angle, MGB's fund acts as a direct conduit to world-class clinical validation.

If you share what your core healthcare IT product does (e.g., AI/ML workflow, RCM, interoperability, EHR add-on) and your current funding stage (Seed vs. Series A/B), I can help map which of these CVCs aligns best with your value proposition.

Yes. I’d treat this as a target-account list for a healthcare IT company, not just a list of organizations that have ever had a venture arm. I searched for evidence of active investing and strategic deployment activity in 2025–2026.

Highest-priority hospital-system CVCs

Insurer / payer CVCs I'd put near the top

My ranking for a healthcare IT startup

If your product is B2B healthcare IT rather than biotech/medical device, I'd prioritize outreach roughly like this:

Tier 1 — strongest combination of capital + strategic fit + current activity

1. CVS Health Ventures
2. Cigna Ventures
3. Kaiser Permanente Ventures
4. UPMC Enterprises
5. Optum Ventures
6. Intermountain Ventures
7. UNC Health Ventures

Tier 2 — very worthwhile 8. Humana Ventures 9. Elevance Health Ventures 10. Mayo Clinic Ventures 11. Cleveland Clinic Ventures 12. HCSC / Cobalt Ventures 13. Allumia Ventures

One particularly interesting signal: UNC just expanded its fund by $125M, while CVS has been making multiple 2026 healthcare-IT investments. That suggests the institutional healthcare CVC market isn't merely sitting on legacy portfolios—there are organizations actively putting strategic capital to work right now.

Where I'd focus depending on your product

• Clinical AI / ambient documentation: UPMC, Kaiser, Mayo, Intermountain, CVS
• Revenue cycle / coding / claims: CVS, Cigna, Optum, HCSC, Elevance
• Provider workflow / enterprise SaaS: UPMC, Intermountain, Kaiser, UNC
• Care management / navigation: Cigna, Humana, CVS, Optum, HCSC
• Patient engagement / consumer health: CVS, Kaiser, Cigna, Humana
• Health-plan infrastructure / payer tech: Optum, Cigna, Elevance, HCSC, Humana

If you tell me what your product does, target buyer (provider vs payer), stage, and approximate raise, I can narrow this to the 10–15 CVCs most likely to actually write your check, including recent portfolio companies, typical check size/stage, partner names, and warm-introduction paths.

For a healthcare IT company, targeting the right Corporate Venture Capital (CVC) arms from major health systems and payers can provide not just capital, but critical pilot environments and enterprise distribution.

The most active and prominent strategic CVCs in the provider (hospital system) and payer (insurance) spaces heavily favor workflow automation, clinical AI, data interoperability, and revenue cycle management (RCM).

Major Payer / Insurance CVCs

• CVS Health Ventures — Frequently ranks as a top growth-stage corporate investor in digital health, focusing on care delivery, pharmacy integration, and consumer-facing health tech.
• Optum Ventures (UnitedHealth Group) — One of the most aggressive institutional CVCs in data analytics, digital care delivery, and infrastructure tools that scale across enterprise payor/provider networks.
• Cigna Ventures — Invests actively in digital health, analytics, and tech-enabled services that streamline care coordination and affordability.
• Humana Ventures — Focuses heavily on senior care delivery, digital therapeutics, and administrative tools tailored around Medicare Advantage populations.
• Blue Venture Funds (BCBS Association / various Blues like CareFirst's Healthworx and BCBS Kansas City's Cobalt Ventures ) — A massive collective network investing in payer-provider convergence and tech solutions that lower medical cost ratios.
• Echo Health Ventures — Strategic fund backed by major Blues plans (like Cambia Health Solutions and Mosaic Health Solutions) explicitly built to bridge mid-to-late stage healthcare IT into regional markets.

Major Hospital System CVCs

• Kaiser Permanente Ventures — Exceptionally active in IT infrastructure, clinical decision support, and virtual care platforms that integrate with integrated delivery networks (IDNs).
• Ascension Ventures — Backed by a massive national health system, focusing on healthcare IT, patient engagement, and operational efficiencies for acute and ambulatory care.
• Mayo Clinic Ventures — Focuses on commercializing and investing in medical technologies, AI diagnostics, and specialized digital health platforms with strong clinical validation potential.
• Cleveland Clinic Ventures — Frequently co-invests and partners with institutional VCs to spin out and fund provider-centric software and clinical innovations.
• Mass General Brigham Ventures — Targets early-to-growth stage digital health and medical tech emerging from clinical settings that can optimize hospital operations.
• Intermountain Ventures — Invests in tools that drive value-based care, remote patient monitoring, and clinical workflow simplification.

If you share your specific product focus (e.g., generative AI documentation, RCM automation, remote patient monitoring, value-based care analytics), I can help you match your solution to the CVCs with the most relevant portfolio alignment and pilot potential.

Yes. If you’re a healthcare IT company, there is a meaningful set of strategic CVCs attached to major health systems and payers. I’d prioritize them differently from a generic healthcare VC because the best ones can provide enterprise customers, pilots, clinical validation, distribution, data access, and payer/provider relationships in addition to capital.

My shortlist

The ones I'd put at the top of your fundraising list

1. Optum Ventures

This is probably the first payer CVC I'd investigate. Optum Ventures says it has $2B+ AUM across six funds and 75+ portfolio companies, investing from seed through growth in areas including enterprise software and enabling infrastructure.

The strategic value is unusually high because you're potentially getting access to the UnitedHealth/Optum ecosystem—not merely another financial investor.

2. CVS Health Ventures

CVS is especially compelling for companies selling workflow, AI, care-delivery or consumer-facing technology. Its current portfolio includes Abridge, CareBridge, Ellipsis Health, Kouper Health, Lynx, Main Street Health, Oshi Health, Strive Health, Thyme Care and others.

CVS says 70%+ of its portfolio companies have established business relationships with CVS Health, which is a very important signal if you're looking for strategic commercialization rather than just capital.

3. Cigna Ventures

Cigna is one of the cleaner matches for enterprise healthcare IT. Its current site reports $700M AUM and 24 investments, with a focus on early/growth-stage whole-person health services and technology.

Its historical portfolio includes Arcadia, Datavant, GNS Healthcare, Prognos, Omada, RecoveryOne and MDLIVE, illustrating that it isn't limited to care-delivery startups.

4. Blue Venture Fund

I'd put this very high if your buyers are health plans. BVF is a collaboration among participating Blue Cross Blue Shield companies and explicitly invests in healthcare technology and technologies that improve health-plan operations. It's also stage agnostic—from seed through growth/buyout.

Its portfolio is unusually relevant to HCIT: HealthEdge, Humata Health, SmartData Solutions, Prove, Lumeris, CirrusMD, emids, Verata Health, Patientco, Phreesia, Picwell, etc.

5. Ascension Ventures

This is probably my favorite provider-side CVC for pure healthcare IT.

Ascension Ventures currently reports $1B+ in capital under management, representing 13 health-system partners and roughly 300 acute-care hospitals. Its investment criteria explicitly include healthcare information technology and services, with typical aggregate investment of $10–20M per company.

Even better, it explicitly describes its role as helping portfolio companies get connected to health systems and influencing product, sales and commercialization strategy.

6. UPMC Enterprises

This one is particularly interesting because UPMC gives you both sides of the market: it is a huge provider and insurer. UPMC Enterprises describes itself as UPMC's innovation, commercialization and venture-capital arm and says it invests in both early- and growth-stage companies.

Provider-side investors I'd also seriously consider

Kaiser Permanente Ventures is a particularly strong target for enterprise HCIT. KPV explicitly targets health information technology/enterprise solutions, digital health and healthcare services, and says it has invested in more than 67 companies.

Intermountain Ventures is another good fit for operational software. Its current focus areas include enterprise enablement, care-site optimization, workforce transformation, consumer experience, clinical advancement and proactive care.

Northwell Holdings is worth looking at if you're selling into large health systems. Northwell describes Holdings as its strategic corporate venture capital and innovation arm, investing in external companies as well as creating new companies, with a focus on solving clinical and operational problems.

And NYU Langone has become more interesting recently: its NYU Langone Venture Fund has made 10 investments over the past four years, including companies involving AI-enabled devices, and its technology organization is actively commercializing software, digital health and AI.

A useful way to segment the targets

I'd actually build your CVC outreach list according to who you sell to:

If you sell to hospitals/providers

• Ascension Ventures
• UPMC Enterprises
• Kaiser Permanente Ventures
• Intermountain Ventures
• Northwell Holdings
• Providence Ventures
• Mayo Clinic Ventures
• NYU Langone
• Cleveland Clinic Ventures

If you sell to payers

• Optum Ventures
• Cigna Ventures
• CVS Health Ventures
• Blue Venture Fund
• Cobalt Ventures
• Humana Ventures
• Elevance/Carelon

If you sell to both payers + providers

• Optum Ventures
• Blue Venture Fund
• Ascension Ventures
• UPMC Enterprises
• Cigna Ventures
• CVS Health Ventures

That last category is especially attractive because the strategic investor can potentially become both an investor and a distribution/customer channel.

One important caveat: having a CVC doesn't mean the parent is actively deploying into new deals in 2026. The CVC landscape has contracted materially overall, so I'd distinguish between funds with an existing portfolio and funds that are demonstrably doing new deals now.

If you tell me what your product does, target buyer (CIO/CMIO/payer/etc.), ACV, stage, and whether you're raising Seed/A/B/etc., I can narrow this to the 10–15 CVCs most likely to invest in you, including recent investments, typical check size, relevant portfolio companies, and the best partner/person to approach.

The most active corporate venture capital (CVC) and strategic investment arms from major health systems and insurance companies actively funding healthcare IT and digital health include Optum Ventures (UnitedHealth Group), CVS Health Ventures, Kaiser Permanente Ventures, Cigna Ventures , and Ascension Ventures.

Major corporate strategic arms target specific facets of the healthcare IT landscape:

Major Health Insurer CVCs

• Optum Ventures : The $2 billion venture fund backed by UnitedHealth Group focuses heavily on data analytics, digital health, and scalable IT infrastructure that reduces administrative drag and hospital readmissions.
• CVS Health Ventures : Focuses on growth-stage digital health, tech-enabled services, and care-delivery innovation connecting retail pharmacy and payer operations.
• Cigna Ventures : Invests strategically in early-to-growth-stage companies digitizing clinical workflows, behavioral health IT, and payer-provider collaboration tools.
• Blue Cross Blue Shield Venture Partners : Highly active collective investing alongside regional plans in care enablement and administrative efficiency software.

Major Health System CVCs

• Kaiser Permanente Ventures : The strategic investment arm of Kaiser Permanente targets clinical technologies, enterprise healthcare IT, and virtual care platforms that integrate smoothly into integrated delivery networks.
• Ascension Ventures : Represents a collaborative of major nonprofit health systems investing in healthcare IT, digital health, and tech-enabled services designed to improve clinical and operational workflows.
• Cleveland Clinic : Continues active structural co-investing and partnership models (such as collaborations with top-tier VCs like Khosla Ventures ) to trial, scale, and fund care-delivery innovations.

If you can share your specific healthcare IT sub-sector (e.g., Revenue Cycle Management, interoperability, clinical AI, or telehealth), I can narrow down which specific CVCs have deployed capital into that exact niche recently.

For a healthcare IT (HCIT) company, targeting Corporate Venture Capital (CVC) arms embedded within major payers and health systems is a smart play—they provide not just capital, but immediate pilot opportunities and enterprise validation.

The corporate venture landscape heavily favors workflow optimization, data interoperability, and practical AI integrations over speculative tools. The most active and prominent strategic CVCs from major health systems and insurance/payer organizations include:

Major Payer / Insurance CVCs

• CVS Health Ventures : Consistently ranks as one of the most active core strategic investors in digital health. They focus heavily on tech-enabled care, primary care innovation, and consumer-facing or workflow solutions that plug into their vast retail, insurance, and pharmacy ecosystem.
• Optum Ventures (UnitedHealth Group): Operating as the independent venture fund of Optum, they actively back digital health, data analytics, and HCIT startups. They look for tools that leverage data to improve care delivery, access, and administrative/payment workflows. They recently participated in rounds for companies like Bunkerhill Health.
• Cigna Ventures : Focuses its investments on three main pillars: insights-driven care, personalization, and operational efficiency. They frequently back digital health and IT solutions that simplify the consumer experience and lower the total cost of care.

Major Health System CVCs & Innovation Arms

• Kaiser Permanente Ventures : One of the longest-standing and most active health system CVCs. They invest heavily in healthcare IT, digital health, and tech-enabled services that can be deployed across Kaiser’s massive integrated delivery network.
• Cleveland Clinic Ventures : Acts as the commercialization and investment arm for the health system, partnering closely with traditional VCs (such as their strategic collaboration with Khosla Ventures) to fund and scale clinical and operational innovations.
• UPMC Enterprises : The commercialization and venture arm of UPMC (University of Pittsburgh Medical Center). Unlike some passive CVCs, UPMC Enterprises often co-creates and builds companies "in-house" alongside external investments, focusing heavily on translational healthcare intelligence and operational IT.
• Providence Ventures : The venture capital arm of Providence, focusing on early- to growth-stage IT and digital health companies that improve clinical workflows, patient engagement, and health system resiliency.
• Ascension Ventures : The strategic venture capital arm of Ascension, investing on behalf of a collaborative group of major Catholic health systems. They specifically look for health IT and services companies that drive clinical quality and operational efficiencies for acute and ambulatory care providers.
• OSF Ventures (OSF HealthCare): Actively invests in early-to-growth-stage companies that enable innovative care delivery, digital transformation, and remote patient monitoring/platforms suited for mid-to-large-size provider networks.

Notable Strategic-Backed Syndicates

• LRVHealth : A prominent venture firm backed by a coalition of major provider, payer, and pharmacy organizations (including several Blue Cross plans and major hospital networks). They act as a collaborative bridge between early-stage HCIT companies and enterprise strategic deployment.
• 7wireVentures : Known for backing the "connected consumer health" ecosystem, operating closely with a coalition of top-tier health plans and health systems to fund workflow and data-driven infrastructure.

If you tell me what specific problem your healthcare IT solution solves (e.g., ambient AI documentation, revenue cycle automation, interoperability, or remote monitoring), I can help you identify which of these specific CVCs is the best tactical fit for a pitch.

Yes. If you're a healthcare IT company looking for strategic CVCs that can invest and potentially become customers, distribution partners, or reference accounts, there is a fairly strong group to target.

I’d divide the market into health-system investors and payer/insurer investors, with a few being especially relevant to healthcare IT.

Highest-priority health-system CVCs

CommonSpirit, UPMC, Mass General Brigham AIDIF and MemorialCare would be near the top of my list if your product is software/AI rather than biotech or medtech.

Payer / insurer CVCs

One particularly interesting category: hybrid payer/provider investors

I'd pay special attention to UPMC Enterprises. UPMC is both a major provider and insurer, and its investment arm explicitly leverages both the clinical side and UPMC Health Plan's payer perspective. That makes it unusually valuable for a healthcare IT company selling into either side of the market.

There's also a broader trend toward these investors demanding commercial/strategic value rather than just financial return. For example, UPMC says it generally wants investments that can actually be used within UPMC, while Mass General Brigham's digital fund explicitly connects investing with testing and deployment inside the system.

My practical ranking

If I were building your fundraising target list, I'd roughly prioritize:

Tier 1 — highly strategic for healthcare IT

1. CommonSpirit Ventures
2. UPMC Enterprises
3. CVS Health Ventures
4. Cigna Ventures
5. Blue Venture Fund
6. Mass General Brigham AIDIF
7. Optum Ventures
8. Echo Health Ventures

Tier 2 — very worthwhile 9. MemorialCare Innovation Fund
10. Ascension Ventures
11. Healthworx Ventures
12. Mass General Brigham Ventures

The important distinction is that the best CVC isn't necessarily the one with the biggest check. For a healthcare IT company, I'd strongly favor investors that can provide enterprise introductions, procurement access, clinical validation, payer contracting, data partnerships, and a path to deployment.

If you tell me what your product does, target buyer (CIO/CMIO/CFO/payer/etc.), stage, and approximate round size, I can narrow this to 10–15 specific CVCs that are most likely to invest, including recent portfolio examples and the best partner/person to approach.